KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amgen (AMGN) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Amgen (AMGN) over the last 17 years, with Q3 2025 value amounting to 0.11.

  • Amgen's Equity Ratio rose 2884.52% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 2884.52%. This contributed to the annual value of 0.06 for FY2024, which is 23.88% down from last year.
  • As of Q3 2025, Amgen's Equity Ratio stood at 0.11, which was up 2884.52% from 0.08 recorded in Q2 2025.
  • Over the past 5 years, Amgen's Equity Ratio peaked at 0.15 during Q1 2021, and registered a low of 0.02 during Q1 2022.
  • Over the past 5 years, Amgen's median Equity Ratio value was 0.07 (recorded in 2025), while the average stood at 0.08.
  • In the last 5 years, Amgen's Equity Ratio plummeted by 8963.22% in 2022 and then surged by 28955.32% in 2023.
  • Amgen's Equity Ratio (Quarter) stood at 0.11 in 2021, then crashed by 48.68% to 0.06 in 2022, then grew by 14.1% to 0.06 in 2023, then dropped by 0.24% to 0.06 in 2024, then soared by 66.76% to 0.11 in 2025.
  • Its Equity Ratio was 0.11 in Q3 2025, compared to 0.08 in Q2 2025 and 0.07 in Q1 2025.